Podlipodcast player Webplayer

Pearls and Prep

Pearls and Prep

Auvelity May Change How You Think About Depression: NMDA, Sigma-1, Dopamine & Clinical Pearls

Pearls and Prep · May 28, 2026 · 22:43

0:0022:43

Listen in the Podli app 🎧

Follow your favourite podcasts, listen offline and in the car with CarPlay and Android Auto, and always pick up where you left off. Free to try.

There are two kinds of clinicians—the ones who follow algorithms, and the ones who understand the “why.”

Patients know the difference. Know the WHY!

Join our clinical library today on PATREON!

👉 https://www.patreon.com/PearlsandPrep

We're diving into the nitty-gritty of a super cool antidepressant called Auvelity today. This bad boy is one of the first fresh faces in the antidepressant world in over 30 years, and it’s not just your run-of-the-mill serotonin booster. We're talking NMDA antagonism and sigma 1 receptor agonism—yeah, that’s some fancy science! We'll chat about a case study featuring Sarah, a marketing manager who's had it up to here with the usual meds that leave her feeling like a zombie. So, grab your headphones and let's unpack how Auvelity could be a game changer for folks who need a quicker fix without the cringe side effects. It’s all about finding that sweet spot where patients can actually feel better and get back to living their lives!

32

Auvelity May Change How You Think About Depression: NMDA, Sigma-1, Dopamine & Clinical Pearls

Pearls and Prep

pearlsandprep@mail.com

https://patreon.com/PearlsandPrep?utm_medium=unknown&utm_source=join_link&utm_campaign=creatorshare_creator&utm_content=copyLink

Takeaways:


Companies mentioned in this episode:




This podcast uses the following third-party services for analysis:

Podcorn - https://podcorn.com/privacy

Episodes: Pearls and Prep

PodliGet the free Podli app
↓ App